<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T22:56:56Z</responseDate>
  <request identifier="oai:figshare.com:article/33742561" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33742561</identifier>
        <datestamp>2026-09-14T14:10:25Z</datestamp>
        <setSpec>portal_1197</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Data for Assessing the detection limit of a minority solid-state form of a pharmaceutical by 1H double-quantum MAS NMR spectroscopy</dc:title>
          <dc:creator>Keisuke Maruyoshi (2566843)</dc:creator>
          <dc:creator>Dinu Iuga (1345257)</dc:creator>
          <dc:creator>Abigail E. Watts (3801910)</dc:creator>
          <dc:creator>Colan E. Hughes (1296822)</dc:creator>
          <dc:creator>Kenneth D.M. Harris (1300911)</dc:creator>
          <dc:creator>Steven P. Brown (1296819)</dc:creator>
          <dc:subject>Drugs -- Testing</dc:subject>
          <dc:subject>Nuclear magnetic resonance spectroscopy</dc:subject>
          <dc:subject>Migrated from ePrints</dc:subject>
          <dc:description>The lower detection limit for two distinct crystalline phases by 1H magic-angle spinning (MAS) solid-state NMR is investigated for a minority amount of cimetidine (anhydrous polymorph A) in a physical mixture with the anhydrous hydrochloride salt of cimetidine. Specifically, two-dimensional 1H double-quantum (DQ) MAS spectra of polymorph A and the anhydrous hydrochloride salt constitute fingerprints for the presence of each of these solid forms. For solid-state NMR data recorded at a 1H Larmor frequency of 850 MHz and a MAS frequency of 30 kHz on ~10 mg of sample, it is shown that, by following the pair of cross peaks at a 1H DQ frequency of 7.4 + 11.6 = 19.0 ppm that are unique to polymorph A, the level of detection for polymorph A in a physical mixture with the anhydrous hydrochloride salt is a concentration of 1% w/w.&lt;br&gt;&lt;br&gt;NMR experimental data set generated using Bruker TOPSPIN software, relating to figures 1 and 2. See README file for more information.</dc:description>
          <dc:date>2017-08-03T00:00:00Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.82444/warw.33742561.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Data_for_Assessing_the_detection_limit_of_a_minority_solid-state_form_of_a_pharmaceutical_by_1H_double-quantum_MAS_NMR_spectroscopy/33742561</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
